Twenty-three (85%) of 27 patients with pancreatic cancer tested for CEA by the method of Gold were positive. The CEA assay was more frequently positive in patients with cancer of the pancreas than were any other diagnostic tests used, including upper gastrointestinal series,g hypotonic duodenography
β¦ LIBER β¦
CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis
β Scribed by Giuseppe Del Favero; Carlo Fabris; Mario Plebani; Aldo Panucci; Antonio Piccoli; Laura Perobelli; Sergio Pedrazzoli; Ugo Baccaglini; Angelo Burlina; Remo Naccarato
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 384 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Carcinoembryonic antigen (CEA) in the di
β
F. V. Ona; N. Zamcheck; P. Dhar; T. Moore; H. Z. Kupchik
π
Article
π
1973
π
John Wiley and Sons
π
English
β 359 KB
π 2 views
The role of the leukocyte adherence inhi
β
F. Meduri; M. G. Doni; R. Merenda; M. Bizzarini; D. Neri; G. E. Gerunda; A. Maff
π
Article
π
1989
π
John Wiley and Sons
π
English
β 357 KB
π 1 views
Evaluation of seven tumor markers (CA 50
β
T. Wobbes; C. M. G. Thomas; M. F. G. Segers; F. M. Nagengast
π
Article
π
1992
π
John Wiley and Sons
π
English
β 489 KB
π 1 views
Serum CA 19-9 in the postsurgical follow
β
Edoardo Beretta; Alberto Malesci; Alessandro Zerbi; Alberto Mariani; Michele Car
π
Article
π
1987
π
John Wiley and Sons
π
English
β 356 KB
π 2 views
Carcinoembryonic antigen and carbohydrat
β
Carlos A. Angel; Charles B. Pratt; Bhaskar N. Rao; Michael J. Schell; David M. P
π
Article
π
1992
π
John Wiley and Sons
π
English
β 428 KB
Diagnostic value of CA 72-4, carcinoembr
β
Victoria Villena; Angel LΓ³pez-Encuentra; JosΓ© Echave-Sustaeta; Pedro MartΓn-Escr
π
Article
π
1996
π
John Wiley and Sons
π
English
β 427 KB
π 1 views
## BACKGROUND. The differential diagnosis of pleural effusion is a frequent clinical problem. Several tumor markers have been evaluated in pleural fluid, but the value of CA 72-4 assay and of combinations of tumor marker assays has not been firmly established. To find a minimally invasive tool for